ALK-Abello AS - Company Profile
Powered by 
All the data and insights you need on ALK-Abello AS in one report.
$295
- Save hours of research time and resources with
our up-to-date ALK-Abello AS Strategy Report
- Understand ALK-Abello AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
ALK-Abello AS Catalyst Calendar
Proactively evaluate ALK-Abello AS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of ALK-Abello AS Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 06 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Nov 2020 | Phase II Trial Initiation | ALK-Abello AS; Division of Allergy Immunology and Transplantation; Immune Tolerance Network; PPD Inc; Regeneron Pharmaceuticals Inc; Rho Inc; The National Institute of Allergy and Infectious Diseases | ALK B; REGN | dupilumab; standardized grass pollen [timothy (Phleum pratense)] allergen extract | Immunology; Ophthalmology; Respiratory | Allergic Rhino-Conjunctivitis; Grass Pollen Allergy; Seasonal Allergic Rhinitis | Clinical Trial Registry |
| 31 Oct 2020 | Phase II Trial Completion | Center Laboratories Inc | 4123 | CS-02 | Metabolic Disorders | Type 2 Diabetes | Clinical Trial Registry |
| 01 Jun 2020 | Phase IV Trial Initiation | Abbott Laboratories; ALK-Abello AG | ABT | standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract | Immunology; Respiratory | Allergic Asthma; Allergic Rhinitis; House Dust Mite Allergy | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer